Author Correction: Supporting US public health experts.

Cohen, Ron; Francois, Cedric; Crowley, John; Hastings, Paul; King, Rachel; Love, Ted W; Maraganore, John; McMurry-Heath, Michelle; Levin, Jeremy

Cohen, Ron; Francois, Cedric; Crowley, John; Hastings, Paul; King, Rachel; Love, Ted W; Maraganore, John; McMurry-Heath, Michelle; Levin, Jeremy.

Afiliação

Cohen R; President and CEO, Acorda Therapeutics, Ardsley, NY, USA.
Francois C; President and CEO, Apellis Pharmaceuticals, Waltham, MA, USA.
Crowley J; Chairman and CEO, Amicus Therapeutics, Cranbury, NJ, USA.
Hastings P; President and CEO, Nkarta Therapeutics, South San Francisco, CA, USA.
King R; CEO, GlycoMimetics, Rockville, MD, USA.
Love TW; President and CEO, Global Blood Therapeutics, South San Francisco, CA, USA.
Maraganore J; CEO, Alnylam Pharmaceuticals, Cambridge, MA, USA.
McMurry-Heath M; President and CEO, Biotechnology Innovation Organization, Washington, DC, USA.
Levin J; Chairman and CEO, Ovid Therapeutics, New York, NY, USA. jlevin@ovidrx.com.

Nat Biotechnol ; 39(1): 115, 2021 Jan.

Article em En | MEDLINE | ID: mdl-33335308

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Nat Biotechnol Assunto da revista: BIOTECNOLOGIA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google